Melanotan-1 vs Melanotan-2: prices, identity and regulatory status (2026)
Melanotan-1 and Melanotan-2 are different research compounds, not substitutes for each other: Melanotan-1 is a 13-amino-acid peptide (C78H111N21O19); Melanotan-2 is a 7-amino-acid peptide (C50H69N15O9). Neither product has a current in-stock price right now. Melanotan-1 shares its active ingredient with an FDA-approved prescription medicine.
Melanotan-1 vs Melanotan-2: current prices and packages
| Compared property | Melanotan-1 | Melanotan-2 |
|---|---|---|
| Category | Cosmetic | Cosmetic |
| Compared package | 10mg | 10mg |
| Lowest current price | No current in-stock price | No current in-stock price |
| Price per labelled mg | — | — |
| Package sizes | 10mg, 20mg | 10mg, 15mg, 20mg, 30mg |
| Vendors with current prices | 0 | 0 |
| Form at this package | No listing | No listing |
| Stock | Out of stock | Out of stock |
Prices exclude shipping. The price per labelled mg is always given per mg, so different package sizes compare directly; it is shown only for single-compound vials and powders with a labelled mass. Blends, capsules, liquids and IU-labelled packages are compared by package total.
Identity, regulatory status and registered research
| Compared property | Melanotan-1 | Melanotan-2 |
|---|---|---|
| Molecular formula | C78H111N21O19 | C50H69N15O9 |
| Molecular weight | 1646.8 g/mol | 1024.2 g/mol |
| Sequence | Ac-Ser-Tyr-Ser-Nle-Glu-His-D-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2 (13 residues) | Ac-Nle-Asp(1)-His-D-Phe-Arg-Trp-Lys(1)-NH2 (7 residues) |
| CAS Registry Number | 75921-69-6 | 121062-08-6 |
| Registered clinical trials | 23 (1 active) · Phase 3: 6, Phase 2: 13, Phase 1: 3 | 1 (1 active) · Phase 2: 1 |
| Human intervention studies | 2 | 2 |
| US regulatory status | FDA-approved prescription medicine with this active ingredient: Scenesse (NDA 210797; checked October 7, 2026)MarketedSCENESSE · NDA 210797 · 2019Research listings are not these medicines. | No reviewed Drugs@FDA record |
Identity data: PubChem, FDA GSRS and EPA records; registry counts: ClinicalTrials.gov; status: Drugs@FDA. A matching name does not verify the contents of a supplier's lot.
Key human studies
Melanotan-1
- Afamelanotide for Erythropoietic Protoporphyria. The New England journal of medicine, 2015
- Afamelanotide and narrowband UV-B phototherapy for the treatment of vitiligo: a randomized multicenter trial. JAMA dermatology, 2015
Melanotan-2
- Melanocortin receptor agonists, penile erection, and sexual motivation: human studies with Melanotan II. International journal of impotence research, 2000
- Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study. Life sciences, 1996
Studies are listed as records, newest first; they are not evidence that a research product is safe or effective.
Where to buy each compound
Melanotan-1
Melanotan-1 is a catalogue entry whose compound-specific reference review has not yet been completed.
No vendor has a current in-stock price for this package.
Melanotan-1 prices →Price history →Melanotan-2
Melanotan-2 is a catalogue entry whose compound-specific reference review has not yet been completed.
No vendor has a current in-stock price for this package.
Melanotan-2 prices →Price history →Questions
Automated price sources are scheduled daily; other sources are checked manually. Check the offer's last successful source timestamp. A code is shown when it is attached to an offer or affiliate link. The displayed price includes a discount only when that code is cart-verified and the discounted price is explicitly recorded; otherwise it is the vendor's listed price. Prices exclude shipping. Stock status is captured at the same time. Rankings are by displayed price, except that the labelled featured partner, LA Peptides, is pinned first; “Cheapest” always marks the lowest price. PeptideTech earns a commission when you buy through a link.
Full method →